Brief: Active Biotech Q3 Operating Loss At SEK 13.4 Million

Active Biotech AB publ

03/11/2022 07:36

Nov 3 (Reuters) - Active Biotech AB publ  ACTI.ST :
    * ACTIVE BIOTECH INTERIM REPORT Q3 2022
    * Q3 OPERATING LOSS SEK 13.4 MILLION

Source text for Eikon:  ID:nMFN95g7dS 
Further company coverage:  ACTI.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))